TP53 mutation is not only the most common genetic event in NSCLC but also reported to be associated with poor prognosis in cancers, especially non-small cell lung cancer (Ozaki and Nakagawara, 2011). This evidence concerns the gene TP53 and non-small cell lung carcinoma.